Bionano Genomics, Inc. (BNGO) vs Femasys Inc. (FEMY)
Bionano Genomics, Inc. and Femasys Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. and Femasys Inc. are of similar size ($20.4M and $19.9M). Femasys Inc. grew revenue faster over the last twelve months: 21.9% against 10.0%. Bionano Genomics, Inc. has the higher net margin (−106.6% vs −534.3%) and the higher return on invested capital (−81.7% vs −176.9%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 14 and Femasys Inc. on 4.
Valuation
Profitability
| Metric | BNGO | FEMY | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 47.51% | 60.95% | 54.62% |
| Operating margin | (106.67%) | (763.90%) | 1.64% |
| Net margin | (106.58%) | (534.27%) | 0.00% |
| Free cash flow margin | (67.87%) | (786.02%) | 1.61% |
| Return on equity | (83.56%) | (443.65%) | 0.00% |
| Return on assets | (52.04%) | (94.25%) | 0.00% |
| Return on invested capital | (81.68%) | (176.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack